Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2013, Article ID 431857, 5 pages
http://dx.doi.org/10.1155/2013/431857
Case Report

Long-Term Survival and Improved Quality of Life following Multiple Repeat Gamma Knife Radiosurgeries for Recurrent Glioblastoma Multiforme: A Case Report and Review of the Literature

1Gamma Knife of Spokane, Cancer Care Northwest, 910 W 5th Avenue, Suite 102, Spokane, WA 99204, USA
2Cancer Care Northwest, 910 W 5th Avenue, Suite 102, Spokane, WA 99204, USA
3University of Washington School of Medicine, 1959 NE Pacific Street, Seattle, WA 98195, USA
4MacKay & Meyer MDs, 711 S Cowley Street, Suite 210, Spokane, WA 99202, USA
5Spokane Brain & Spine, 801 W 5th Avenue, Suite 210, Spokane, WA 99204, USA

Received 9 July 2013; Accepted 27 August 2013

Academic Editors: J. M. Buchanich, F. A. Mauri, R. Palmirotta, and K. Tanaka

Copyright © 2013 Erik W. Larson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. L. Goodenberger and R. B. Jenkins, “Genetics of adult glioma,” Cancer Genetics, vol. 205, no. 12, pp. 613–621, 2012. View at Google Scholar
  2. D. Krex, B. Klink, C. Hartmann et al., “Long-term survival with glioblastoma multiforme,” Brain, vol. 130, no. 10, pp. 2596–2606, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. K.-J. Park, H. Kano, A. Iyer et al., “Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study,” Journal of Neuro-Oncology, vol. 107, pp. 323–333, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Patel, F. Siddiqui, J.-Y. Jin et al., “Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival,” Journal of Neuro-Oncology, vol. 92, no. 2, pp. 185–191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Li, M. Wang, M. Won et al., “Validation and simplification of the radiation therapy oncology group recursive partitioning analysis classification for glioblastoma,” International Journal of Radiation Oncology Biology Physics, vol. 81, no. 3, pp. 623–630, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. F. C. Barker II, S. M. Chang, P. H. Gutin et al., “Survival and functional status after resection of recurrent glioblastoma multiforme,” Neurosurgery, vol. 42, no. 4, pp. 709–720, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. K. L. Chaichana, P. Zadnik, J. D. Weingart et al., “Multiple resections for patients with glioblastoma: prolonging survival,” Neurosurgery, vol. 118, no. 4, pp. 812–820, 2013. View at Google Scholar
  8. G. E. Keles, B. Anderson, and M. S. Berger, “The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere,” Surgical Neurology, vol. 52, no. 4, pp. 371–379, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Sanai, M.-Y. Polley, M. W. McDermott, A. T. Parsa, and M. S. Berger, “An extent of resection threshold for newly diagnosed glioblastomas: clinical article,” Journal of Neurosurgery, vol. 115, no. 1, pp. 3–8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. L. C. Hou, A. Veeravagu, A. R. Hsu, and V. C. K. Tse, “Recurrent glioblastoma multiforme: a review of natural history and management options,” Neurosurgical Focus, vol. 20, no. 4, pp. 1–9, 2006. View at Google Scholar · View at Scopus
  11. P. De Bonis, C. Anile, A. Pompucci et al., “The influence of surgery on recurrence pattern of glioblastoma,” Clinical Neurology and Neurosurgery, vol. 115, pp. 37–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. B. S. Skeie, P. Ø. Enger, J. Brøgger et al., “Gamma knife surgery versus reoperation for recurrent glioblastoma multiforme,” World Neurosurgery, vol. 78, no. 6, pp. 658–669, 2012. View at Google Scholar
  13. N. Pouratian, R. W. Crowley, J. H. Sherman, J. Jagannathan, and J. P. Sheehan, “Gamma Knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma,” Journal of Neuro-Oncology, vol. 94, no. 3, pp. 409–418, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Souhami, W. Seiferheld, D. Brachman et al., “Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of radiation therapy oncology group 93-05 protocol,” International Journal of Radiation Oncology Biology Physics, vol. 60, no. 3, pp. 853–860, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. P. C. Hsieh, J. P. Chandler, S. Bhangoo et al., “Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme,” Neurosurgery, vol. 57, no. 4, pp. 684–692, 2005. View at Google Scholar · View at Scopus
  16. T. Koga, K. Maruyama, M. Tanaka et al., “Extended field stereotactic radiosurgery for recurrent glioblastoma,” Cancer, vol. 118, no. 17, pp. 4193–4200, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. E. A. Monaco III, A. Niranjan, H. Kano, J. C. Flickinger, D. Kondziolka, and L. D. Lunsford, “Management of adverse radiation effects after radiosurgery,” Progress in Neurological Surgery, vol. 25, pp. 210–220, 2012. View at Google Scholar
  18. H. Kano, D. Kondziolka, J. Lobato-Polo, O. Zorro, J. C. Flickinger, and L. D. Lunsford, “T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery,” Neurosurgery, vol. 66, no. 3, pp. 486–491, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Stupp, M. E. Hegi, W. P. Mason et al., “Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial,” The Lancet Oncology, vol. 10, no. 5, pp. 459–466, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Khasraw, M. Simeonovic, and C. Grommes, “Bevacizumab for the treatment of high-grade glioma,” Expert Opinion on Biological Therapy, vol. 12, no. 8, pp. 1101–1111, 2012. View at Google Scholar
  21. A. Lai, A. Tran, P. L. Nghiemphu et al., “Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme,” Journal of Clinical Oncology, vol. 29, no. 2, pp. 142–148, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Cecchi, M. Vaiani, M. Ceroti, and R. Banfi, “A retrospective observational analysis to evaluate the off-label use of bevacizumab alone or with irinotecan in recurrent glioblastoma,” International Journal of Clinical Pharmacy, vol. 35, no. 3, pp. 483–487, 2013. View at Google Scholar